Peter Crane
Founder of Caeruleus Genomics
Peter Crane
Founder of Caeruleus Genomics
Oxford, England
Overview
Work Experience
Co-Founder and CEO
2023 - Current
Every patient's cells have a longer story to tell
Venture Partner (Techbio)
2022
Investing in the frontier of computer science and biology/chemistry Pre-seed to Seed | Tickets up to 1M Euros Peter[at]lunar.vc
Vice President Strategy
2022 - 2022
Infinitopes is a pioneer in precision immunomics medicines. A Cancer Research UK (CRUK)-a led biotech spinout from Oxford University, we empower the immune system to fight cancer metastases with unique, de novo antigen discovery technologies, innovative high-efficiency vectors and intelligent clinical trial design.
Principal
2021 - 2021
On Investment Team. Deals included: Phenomic.AI (seed), Living Optics (seed), Kernal Biologics (pre-seed), Cytoseek (seed), Biomage (pre-seed, aquired) and Molecule One (seed).
Corporate Strategy Manager
2019 - 2021
Focus on digital tooling in bioprocessing, gene therapy, protein engineering and lab automation.
Business Development
2017 - 2019
Venture Partner
2018 - 2021
New Ventures Associate: Life-Sciences Ventures
2016 - 2017
Worked for a leading pharma company with a focus on therapeutic deal sourcing and evaluation
Chief Global Business Development Officer | Founding Member
2014 - 2017
CASE Placement (Discovery Biology)
2014 - 2015
Chapter President
2013 - 2014